Higer Health Sciences: Powering the Future of Nutraceutical Manufacturing with Innovation & Precision

Sonar Parikh, Founder

Sonar Parikh

Founder

The nutraceutical and health supplement industry has witnessed a remarkable transformation over the past decade, evolving from a niche wellness segment into a cornerstone of preventive healthcare. As consumers become increasingly health-conscious, the demand for scientifically formulated supplements, functional foods, and clean-label nutrition continues to rise.

This shift has created a parallel need for reliable, agile, and innovation-driven contract man­ufacturing partners who can bring health-focused ideas to life with speed and precision. In this dynamic landscape, contract manufacturers are no longer just production units, they are strategic collaborators offering end-to-end solu­tions, from concept development to market-ready products.

Amid this evolution, Higer Health Sciences has emerged as a forward-looking player, contributing significantly to the industry by enabling brands to innovate, scale, and deliver high-quality nutraceutical solutions aligned with modern consumer expectations.

A Versatile Manufacturing Partner for a Dynamic Market

Higer Health Sciences has positioned itself as a flexible and solution-driven contract manufacturer, catering to the evolving needs of both emerging startups and established brands. In today’s competitive landscape, clients seek part­ners who can offer speed, customization, and a diverse range of product capabilities under one roof.

Higer address­es this demand through its dual manufacturing facilities, which are designed to support both small pilot batches and large-scale production.

From as low as 10 kilograms for product trials to volumes reaching 12,000 kilograms, the company ensures seamless scalability for its clients. This ability to adapt across production volumes allows brands to test new concepts with minimal risk while also preparing for rapid market expansion.

With a strong emphasis on private labelling and customization, Higer empowers its partners to create differentiated, market-ready products tailored to specific consumer needs.

Higer Health Sciences has positioned itself as a flexible and solution-driven contract manufacturer, catering to the evolving needs of both emerging startups and established brands

Sonar Parikh, Founder

End-to-End Capabilities Driving Innovation

At the core of Higer Health Sciences lies a comprehensive, end-to-end manufacturing model that transforms ideas into tangible products. The company’s capabilities extend across the entire value chain - from concept ideation and formu­lation development to sourcing, manufacturing, packaging, and regulatory support.

This integrated approach simplifies the product development journey for clients, enabling faster time-to-market and greater efficiency.

Higer specializes in a wide array of product formats, reflecting the diversity of modern nutraceutical consumption. Its portfolio includes table-top sweeteners, zero-sugar hydration solutions, weight management sachets, functional premixes such as tea, coffee, and hot chocolate blends, as well as advanced formulations like prebiotic fibers and gut health supplements.

Additionally, the company manufactures nutraceutical capsules designed to meet evolving health requirements. This broad spectrum not only highlights Higer’s technical expertise but also reinforces its ability to stay aligned with emerging health trends and consumer preferences.

Quality, Compliance, and Consistency at the Core

In the nutraceutical industry, quality and regulatory compliance are non-negotiable. Higer Health Sciences places these principles at the center of its operations, ensuring that every product meets stringent safety and efficacy standards. The company follows well-defined protocols across all stages of production, beginning with the sourcing of raw materials and packaging components and extending to final product dispatch.

Its manufacturing processes are aligned with Good Manufacturing Practices (GMP), supported by detailed standard operating procedures and robust batch traceability systems. A dedicated quality assurance team works in tandem with quality control units to conduct in-process checks, as well as testing at both semi-finished and finished stages.

Regular audits, equipment calibration, and continuous staff training further reinforce the company’s commitment to excellence. This meticulous approach ensures consistency across batches, building trust with clients and end consumers alike.

Technology Integration for Scalable Growth

Recognizing the importance of technology in modern manufacturing, Higer Health Sciences has integrated advanced digital tools into its operations. Its plant management software plays a crucial role in streamlining production planning, inventory management, and material dispensing processes. This system-driven approach enhances traceability, reduces errors, and ensures batch-to-batch consistency.

The company is also exploring the potential of artificial intelligence and data-driven analytics to further optimize its operations. From demand forecasting to quality analysis and process improvements, these technologies enable smarter decision-making and improved efficiency. By leveraging automation and digital systems, Higer not only enhances productivity but also ensures faster turnaround times, an essential factor in today’s fast-paced market environment.

A Growth Journey Rooted in Innovation

Higer Health Sciences’ journey reflects a steady evolution driven by innovation and strategic expansion. What began as a focused sweetener manufacturing setup has grown into a comprehensive nutraceutical solutions provider. Over the years, the company has expanded its product portfolio to include advanced health formulations, catering to a wide range of consumer needs.

Its ability to support low minimum order quantities while simultaneously handling large-scale production has enabled it to build a diverse client base across domestic and international markets. Continuous investments in infrastructure, quality systems, and product development have further strengthened its position as a reliable and forward-thinking manufacturing partner.

As the nutraceutical industry continues to grow, Higer Health Sciences is focused on positioning itself as a globally recognized, innovation-led manufacturing partner. The company aims to expand into advanced, science-backed formulations and next-generation delivery formats, including functional sachets and ready-to-drink solutions.

With a strong emphasis on clean-label products, improved bioavailability, and sustainable packaging, Higer is aligning its future strategy with global health and environmental trends. By continuing to invest in technology, innovation, and scalable solutions, the company is well-equipped to shape the next phase of growth in the nutraceutical manufacturing sector - both in India and beyond.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2026 India Pharma Outlook. All Rights Reserved.